
zzso zzso zzso and acute zzso leukemia zzso after high-dose chemotherapy zzso and zzso stem cell transplantation zzso for zzso diseases have become an important zzso The zzso risk has zzso but has often been high if compared to the risk after conventional zzso Prior chemotherapy with large cumulative doses of zzso agents is the most important risk zzso In addition, patient age and previous zzso particularly the use of total body zzso zzso in the zzso regimen for zzso have been identified as risk zzso In 3 studies, patients transplanted with zzso zzso from peripheral blood after chemotherapy zzso showed a higher risk of zzso or zzso than patients transplanted with cells isolated from the bone zzso without zzso To what extent this higher risk relates to the prior therapy with a different contamination with zzso zzso precursors of the zzso cells obtained by the 2 methods, or is a direct result of chemotherapy zzso or of an increasing awareness of these zzso remains to be zzso The zzso period from zzso to zzso and zzso has often been short, 12 months or less in zzso of the zzso Bone zzso pathology of early cases of zzso after zzso has often been neither diagnostic nor zzso but most patients presented zzso zzso primarily deletions or loss of the long arms of zzso 5 and zzso The prognosis was in general poor, although zzso with zzso zzso survived more than 18 months from diagnosis, and most of these presented a normal zzso or a single zzso zzso 

